Ryman Healthcare Limited (RYHTY)
For informational purposes only. Not financial advice. Analysis by Sedat ANAK, Founder & Editor-in-Chief | AI-powered analysis. Data sourced from SEC filings and institutional-grade financial providers. Editorially reviewed. Not financial advice.
Ryman Healthcare Limited (RYHTY) trades at $6.20. Ryman Healthcare Limited develops, owns, and operates integrated retirement villages and care facilities in New Zealand and Australia. Market cap: $1.26B, Sector: Healthcare.
Price live · AI analysis from Mar 17, 2026Analyst Coverage for RYHTY: RYHTY does not currently have published analyst price targets in our coverage universe. This is common for smaller-cap names with limited Wall Street coverage. In the absence of analyst consensus, our AI model evaluates RYHTY against Healthcare peers across nine fundamental dimensions and assigns an underweight signal based on the underlying data.
RYHTY: 1/1 perspectives are bearish.
How is this calculated? →Ryman Healthcare Limited (RYHTY) Healthcare & Pipeline Overview
Ryman Healthcare Limited, a leading provider of integrated retirement villages and aged care facilities in New Zealand and Australia, offers a comprehensive range of living and care options. Operating 45 villages, the company focuses on providing high-quality services and amenities for the elderly, positioning itself in a growing healthcare market.
What Is the Investment Thesis for RYHTY?
Ryman Healthcare Limited presents a mixed investment case. While the aging population in New Zealand and Australia provides a strong tailwind for demand, the company's negative profit margin of -75.9% raises concerns about its financial performance. The low beta of 0.22 suggests relatively low volatility compared to the market. Key growth catalysts include the expansion of existing villages and the development of new facilities to meet increasing demand. However, investors should closely monitor the company's ability to improve profitability and manage operational costs. The absence of a dividend yield may deter income-focused investors.
Based on FMP financials and quantitative analysis
RYHTY Key Highlights
- Operates 45 retirement villages across New Zealand and Australia as of May 20, 2022.
- Provides 8,538 retirement village units and 4,239 care units, offering a comprehensive range of aged care services.
- Negative profit margin of -75.9% indicates significant challenges in achieving profitability.
- Low beta of 0.22 suggests lower volatility compared to the overall market.
- No dividend yield may impact attractiveness to income-seeking investors.
Who Are RYHTY's Competitors?
RYHTY is benchmarked below against 8 industry peers on price, market cap, and our AI MoonshotScore.
| Company | Price | Change | Market Cap | AI Score |
|---|---|---|---|---|
| CSPHF CStone Pharmaceuticals | $0.69 | +16.81% | $1.11B | 50 |
| GNTLF Genetic Technologies Limited | $1.00 | +0.00% | $1.34B | 44 |
| LTGHF Life Healthcare Group Holdings Limited | $0.72 | -11.53% | $1.03B | 44 |
| LTGHY Life Healthcare Group Holdings Limited | $2.64 | +3.57% | $944.48M | 42 |
| LWSCF Sienna Senior Living Inc. | $15.71 | +1.81% | $1.56B | 49 |
| HWAIF Healwell AI Inc. | $0.53 | -3.52% | $160.75M | 65 |
| ASSF Assisted 4 Living, Inc. | $1.00 | +0.00% | $45.35M | 63 |
| FTRP Field Trip Health Ltd. | $0.84 | +1.07% | $9.81M | 62 |
AI Score by Stock Expert AI · Price data: FMP / Yahoo Finance
What Are RYHTY's Key Strengths?
- Integrated model providing a continuum of care.
- Established brand reputation in New Zealand and Australia.
- High-quality facilities and comprehensive amenities.
- Experienced management team.
What Are RYHTY's Weaknesses?
- Negative profit margin.
- High capital expenditure requirements for village development.
- Exposure to regulatory changes in the aged care sector.
- Reliance on occupancy rates to maintain profitability.
What Could Drive RYHTY Stock Higher?
- Expansion of existing retirement villages to increase capacity and revenue.
- Development of new retirement villages in underserved areas.
- Increased focus on providing specialized dementia care services.
- Implementation of new technologies to improve care delivery and operational efficiency.
- Strategic partnerships with healthcare providers and community organizations.
What Are the Key Risks for RYHTY?
- Financial-distress signal — its Altman Z-Score of 0.42 sits in the distress zone (elevated bankruptcy risk).
- Negative return on equity (-4.2%) — the business is not currently generating profit on shareholder capital.
- Negative profit margin impacting financial performance.
- Rising operating costs, including labor and utilities.
- Economic downturn impacting occupancy rates.
- Changes in government funding and regulations affecting the aged care sector.
- Limited liquidity due to trading on the OTC market.
What Are the Growth Opportunities for RYHTY?
- Expansion of Existing Villages: Ryman Healthcare can increase capacity and revenue by expanding its existing retirement villages. Adding new units and care facilities to established locations allows the company to leverage existing infrastructure and community relationships. This strategy can be executed relatively quickly, with new phases of development potentially adding hundreds of units per village within a 2-3 year timeframe. The market for retirement village units is projected to grow by 5-7% annually in key regions.
- Development of New Villages: Building new retirement villages in underserved areas presents a significant growth opportunity. Identifying locations with high demand and limited supply allows Ryman Healthcare to capture new market share. Each new village represents a substantial investment, but also a significant revenue stream once operational. The development timeline for a new village is typically 3-5 years, with potential for long-term growth and profitability.
- Increased Focus on Dementia Care: With the aging population, the demand for specialized dementia care is increasing. Ryman Healthcare can capitalize on this trend by expanding its dementia care facilities and services within its villages. This includes creating specialized units, training staff in dementia care, and implementing innovative therapies. The market for dementia care is projected to grow by 8-10% annually, offering a significant opportunity for Ryman Healthcare.
- Technological Innovation: Implementing new technologies to improve care delivery and operational efficiency can drive growth. This includes using telehealth for remote monitoring, implementing electronic health records, and utilizing data analytics to optimize resource allocation. Technology can also enhance the resident experience, with features such as smart home automation and virtual reality entertainment. Investing in technology can differentiate Ryman Healthcare from competitors and attract tech-savvy residents.
- Strategic Partnerships: Forming partnerships with healthcare providers, universities, and community organizations can expand Ryman Healthcare's reach and enhance its service offerings. Collaborating with hospitals and clinics can provide residents with access to specialized medical care. Partnering with universities can facilitate research and development in aged care. Working with community organizations can promote social engagement and integration. Strategic partnerships can create synergies and drive growth for Ryman Healthcare.
What Opportunities Does RYHTY Have?
- Expansion into new geographic markets.
- Increased focus on dementia care services.
- Adoption of new technologies to improve care delivery.
- Strategic partnerships with healthcare providers.
What Threats Does RYHTY Face?
- Increased competition from other retirement village operators.
- Rising operating costs, including labor and utilities.
- Economic downturn impacting occupancy rates.
- Changes in government funding and regulations.
What Are RYHTY's Competitive Advantages?
- Integrated Model: Provides a full continuum of care, attracting residents seeking long-term security.
- Established Brand: Strong reputation and brand recognition in New Zealand and Australia.
- High-Quality Facilities: Well-designed villages with comprehensive amenities.
- Scalability: Potential to expand existing villages and develop new locations.
What Does RYHTY Do?
Founded in 1984 and headquartered in Christchurch, New Zealand, Ryman Healthcare Limited has grown to become a prominent developer, owner, and operator of retirement villages and aged care facilities. The company's integrated model provides a continuum of care, encompassing independent living units, serviced apartments, and full-care centers. These centers offer rest home, hospital, dementia-level care, and respite services. Ryman Healthcare's villages are designed to offer a vibrant and supportive community, featuring amenities such as all-weather bowling greens, indoor heated swimming pools, gyms, libraries, dining rooms, internet cafes, and movie theaters. As of May 20, 2022, Ryman Healthcare operated 45 retirement villages comprising 8,538 retirement village units and 4,239 care units across New Zealand and Australia. The company's commitment to providing comprehensive care and lifestyle options has established it as a key player in the aged care sector.
What Products and Services Does RYHTY Offer?
- Develops and operates integrated retirement villages.
- Provides independent living units, serviced apartments, and full-care centers.
- Offers rest home, hospital, dementia-level care, and respite services.
- Creates communities with amenities like bowling greens, swimming pools, and libraries.
- Operates 45 retirement villages in New Zealand and Australia.
- Provides a continuum of care for the elderly.
How Does RYHTY Make Money?
- Generates revenue from the sale and lease of retirement village units.
- Earns income from providing care services, including rest home, hospital, and dementia care.
- Collects fees for amenities and services offered within the villages.
- Utilizes an integrated model to provide a full continuum of care.
What Industry Does RYHTY Operate In?
Ryman Healthcare operates within the growing aged care industry, driven by the increasing elderly population in New Zealand and Australia. The market is characterized by rising demand for retirement living and care services. Competition includes other retirement village operators and aged care providers. Ryman Healthcare differentiates itself through its integrated model, offering a full continuum of care within its villages. The industry faces regulatory oversight and evolving consumer preferences, requiring operators to adapt and innovate to meet changing needs.
Who Are RYHTY's Key Customers?
- Elderly individuals seeking independent living in a retirement community.
- Individuals requiring assisted living or full-care services.
- Families seeking care options for their elderly relatives.
- Residents in New Zealand and Australia.
Company Profile
Ryman Healthcare Limited operates in the Medical - Care Facilities industry within the Healthcare sector. It is headquartered in Christchurch, NZ. The company is led by CEO Naomi James. RYHTY has traded publicly since 2013.
F-Score 4/9Financial Health
Ryman Healthcare Limited's Piotroski F-Score is 4/9, a 9-point checklist of profitability, leverage and efficiency — a middling fundamental profile. Its Altman Z-Score of 0.42 places it in the distress zone, a signal of elevated financial risk.
ROE -4%Key Financial Metrics
Return on equity for Ryman Healthcare Limited stands at -4.2%, a gauge of how efficiently it converts shareholder capital into profit. Return on assets is -1.4%, showing how much profit it generates from its asset base. Its free cash flow yield is 12.4%, a gauge of the cash the business throws off relative to its market value. A current ratio of 0.55 means current liabilities exceed short-term assets, a liquidity point worth watching. Its earnings yield is -7.8%, the inverse of the P/E and a quick read on earnings relative to price.
RYHTY Valuation & Market Position
With a $1.26B market cap, Ryman Healthcare Limited sits in the small-cap segment of the market.
FY2026 estForward Outlook
Wall Street analysts project Ryman Healthcare Limited revenue of about $851.2M for fiscal 2026, with EPS near $0.00. The estimate reflects 3 contributing analysts.
RYHTY Financials
Fundamental Snapshot
Based on FMP financials and quantitative analysis · FY 2026
Bull Case vs Bear Case
Bull Case
- Ryman's focus on luxury retirement living aligns with the aging population trend, potentially driving demand.
- Insider buying activity suggests confidence in the company's future prospects, a positive signal for investors.
- Community sentiment indicates a belief in Ryman's long-term growth strategy despite short-term market volatility.
- The company's established brand reputation and history in the retirement sector provide a competitive advantage.
Bear Case
- Increased competition in the retirement living sector could erode Ryman's market share and profitability.
- Rising construction costs and interest rates may negatively impact Ryman's development projects and financial performance.
- Community discussions reveal concerns about potential regulatory changes affecting the retirement industry.
- Negative market perception stemming from broader economic uncertainty could pressure Ryman's stock performance, similar to how general market downturns affected healthcare stocks in the past.
AI-generated arguments based on insider flow, news sentiment and technicals — not financial advice · March 2026
RYHTY Latest News
No recent news available for RYHTY.
RYHTY Analyst Consensus
Consensus Rating
Aggregated Buy/Hold/Sell recommendations from Benzinga, Yahoo Finance, and Finnhub for RYHTY.
Price Targets
Wall Street price target analysis for RYHTY.
RYHTY MoonshotScore
What does this score mean?
The MoonshotScore rates RYHTY's growth potential on a scale of 0-100 across multiple factors including innovation, market disruption, financial health, and momentum.
Leadership: Naomi James
CEO
Naomi James is the Chief Executive Officer of Ryman Healthcare Limited. Her background includes extensive experience in healthcare management and operations. Prior to joining Ryman Healthcare, she held leadership positions in various healthcare organizations, focusing on improving patient care and operational efficiency. She has a strong track record of driving growth and innovation in the healthcare sector. Her expertise encompasses strategic planning, financial management, and team leadership.
Track Record: As CEO of Ryman Healthcare, Naomi James is responsible for overseeing the company's operations and strategic direction. Under her leadership, Ryman Healthcare has continued to expand its network of retirement villages and enhance its service offerings. She has focused on improving the quality of care and resident satisfaction, while also driving financial performance. Her tenure has been marked by a commitment to innovation and sustainability.
Ryman Healthcare Limited ADR Information Unsponsored
An American Depositary Receipt (ADR) is a certificate representing shares of a foreign company trading on U.S. stock exchanges. RYHTY is an ADR representing shares of Ryman Healthcare Limited, a New Zealand-based company. This allows U.S. investors to invest in Ryman Healthcare without directly dealing with foreign exchanges, simplifying the process of international investing.
- Home Market Ticker: New Zealand Stock Exchange (NZX), New Zealand
- ADR Level: 1
- ADR Ratio: 1:1
- Home Market Ticker: RYHT
RYHTY OTC Market Information
The OTC Other tier represents the lowest tier of the over-the-counter (OTC) market. Companies in this tier often have limited financial disclosure and may not meet the listing requirements of major exchanges like the NYSE or NASDAQ. Investing in OTC Other stocks carries higher risks due to the potential for less transparency and regulatory oversight compared to exchange-listed companies. Investors should exercise caution and conduct thorough due diligence before investing in OTC Other stocks.
- OTC Tier: OTC Other
- Disclosure Status: Unknown
- Limited financial disclosure increases the risk of investing in RYHTY.
- Low trading volume can result in illiquidity and price volatility.
- OTC Other tier stocks are subject to less regulatory oversight.
- Potential for wider bid-ask spreads can increase transaction costs.
- The 'Unknown' disclosure status makes it difficult to assess the company's financial health.
- Verify the company's registration and regulatory filings.
- Review any available financial statements and disclosures.
- Assess the company's business model and competitive position.
- Evaluate the management team and their track record.
- Monitor trading volume and price volatility.
- Understand the risks associated with investing in OTC Other stocks.
- Consult with a financial advisor before making any investment decisions.
- Ryman Healthcare Limited is an established company with a long operating history.
- The company operates in the regulated healthcare sector.
- The company has a physical presence and operates retirement villages in New Zealand and Australia.
- Naomi James is the CEO of Ryman Healthcare Limited, managing 7700 employees.
- The company was founded in 1984.
Common Questions About RYHTY (Healthcare)
What does Ryman Healthcare Limited do?
Ryman Healthcare Limited develops, owns, and operates integrated retirement villages and aged care facilities in New Zealand and Australia. The company provides a continuum of care, offering independent living units, serviced apartments, and full-care centers. Their villages feature amenities such as bowling greens, swimming pools, and libraries, creating supportive communities for the elderly. Ryman Healthcare's integrated model and established brand differentiate it in the competitive aged care market.
What do analysts say about RYHTY stock?
As of March 17, 2026, formal analyst ratings for RYHTY are limited due to its OTC listing. Key valuation metrics, such as the negative P/E ratio, reflect current profitability challenges. Growth considerations center on the company's ability to expand its village network and improve operational efficiency. Investors should conduct their own thorough analysis, considering the company's financial performance, industry trends, and risk factors. No buy or sell recommendations are made.
What are the main risks for RYHTY?
The main risks for Ryman Healthcare Limited include its negative profit margin, which raises concerns about its financial sustainability. Rising operating costs, economic downturns impacting occupancy rates, and changes in government funding and regulations also pose significant challenges. Additionally, the limited liquidity associated with trading on the OTC market increases the risk for investors. These factors should be carefully considered before investing in RYHTY.
What are the key factors to evaluate for RYHTY?
Evaluate RYHTY on fundamentals, analyst consensus, and risk factors. Not financial advice.
How frequently does RYHTY data refresh on this page?
RYHTY prices update in real time during U.S. market hours. Fundamentals refresh after quarterly filings; analyst ratings and AI insights update daily; news is aggregated continuously.
What has driven RYHTY's recent stock price performance?
Ryman Healthcare Limited (RYHTY) moves on earnings results, analyst revisions, sector rotation, and market sentiment. Notable catalyst: Integrated model providing a continuum of care. See the News tab for the latest drivers. Past performance does not predict future results.
Should investors consider RYHTY overvalued or undervalued right now?
Valuing Ryman Healthcare Limited (RYHTY) requires multiple metrics. Compare P/E, P/S, and EV/EBITDA against sector peers for a full view.
What research should beginners do before buying RYHTY?
Before investing in Ryman Healthcare Limited (RYHTY), research these four areas: (1) the company's revenue model and competitive position (see Company Overview), (2) financial health through revenue growth, margins, and cash flow (see MoonshotScore), (3) what Wall Street analysts recommend and their price targets (see Analyst tab), and (4) specific risk factors that could impact the stock (see Risk Factors section).
Disclaimer: This content is for informational purposes only and does not constitute investment advice. Always do your own research and consult a financial advisor.
Official Resources
Data provided for informational purposes only.
- Limited analyst coverage due to OTC listing.
- Financial data based on available information as of May 20, 2022.